Want to know more about PrimeCell Therapeutics a.s.? Create and verify your free account to access full information.Create your free account

🏛️PrimeCell Therapeutics a.s.

General information

The entity called PrimeCell Therapeutics a.s. is part of the entity of the public sector of Czechia that carries out public procurement, that is, that invests part of the assigned budget in hiring people or companies to fulfill its objectives.

CountryCzechia Postal code110 00 Total contracted amountCZK 1,461,629,048.13 Number of procurement processes32

Most frequent suppliers

The entity PrimeCell Therapeutics a.s. has established relationships with 5 different suppliers through its procurement activities.

This diversity in suppliers promotes competition, ensures better value for money, and reduces dependency on single vendors.

SupplierNo. ContractsTotal amount
🇨🇿 OHL ŽS, a.s.271,440,175,386 CZK
🇨🇿 Centroprojekt Group a.s.216,212,080 CZK
🇨🇿 INKOS-OSTRAVA, a.s.11,980,000 CZK
🇨🇿 LIGNIS s.r.o.11,614,888 CZK
🇨🇿 MERCI, s.r.o.11,646,694 CZK

Contracts

This entity has participated in 32 contracts for a total value of CZK 1,461,629,048.13

These contracts represent the entity's investment in goods, services, and infrastructure to fulfill its public service objectives.

# Contracts
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
DescriptionSupplierAmountDate
🇨🇿 Dodatecne stavebni prace c. 2 "4MEDi - Corporate Biotech Park For Medical Innovations Ostrava"🇨🇿 OHL ŽS, a.s.1,329,662 CZK2015-10-27
🇨🇿 Prelozka horkovodu - priprava realizace projektu 4MEDi🇨🇿 OHL ŽS, a.s.2,464,429 CZK2010-06-07
🇨🇿 4MEDi - Corporate Biotech Park For Medical Innovations Ostrava🇨🇿 OHL ŽS, a.s.669,362,525 CZK2012-04-07
🇨🇿 Dodatecne stavebni prace c. 6 "4MEDi - Corporate Biotech Park For Medical Innovations Ostrava"🇨🇿 OHL ŽS, a.s.2,621,576 CZK2015-10-21
🇨🇿 4MEDI - CORPORATE BIOTECH PARK FOR MEDICAL INNOVATIONS OSTRAVA - VUKON TDI A BOZP🇨🇿 INKOS-OSTRAVA, a.s.1,980,000 CZK2012-11-12
View all contracts

Market context and opportunities

As part of the public sector in Guatemala, this entity plays a crucial role in public service delivery and infrastructure development.

The entity PrimeCell Therapeutics a.s. regularly publishes procurement opportunities for suppliers interested in providing goods and services to the public sector.

With 32 contracts and a total value of 1,461,629,048.13 Q, this entity demonstrates active participation in public procurement.

The entity PrimeCell Therapeutics a.s. has maintained consistent procurement activity over 22 years, showing stable budget allocation and project management.

Public sector context

As a entity entity, PrimeCell Therapeutics a.s. serves essential public functions and contributes to Czechia's development through responsible procurement practices.

This entity is committed to transparency in public procurement, making contract information publicly available as required by Czechia law.

Citizens can monitor the procurement activities of PrimeCell Therapeutics a.s. through public databases and transparency portals.

The entity PrimeCell Therapeutics a.s. has awarded 32 contracts, all of which are publicly accessible for citizen oversight and accountability.

Data sources

Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.

OpenTender

Published byOpentender.eu
CountriesCzechia
LicenseCC BY-NC-SA 4.0
Year range2020 - NaN
Update statusNot updated (No.)
OpenTender obtains information from the Public Procurement Bulletin of the Ministry of Local Development of the Czech Republic.
This record last updated2016-03-05

Links